Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Nov 3;1(6):363. doi: 10.1007/s42979-020-00383-w

Deep Learning Applications to Combat Novel Coronavirus (COVID-19) Pandemic

Amanullah Asraf 1, Md Zabirul Islam 1, Md Rezwanul Haque 1, Md Milon Islam 1,
PMCID: PMC7607889  PMID: 33163975

Abstract

During this global pandemic, researchers around the world are trying to find out innovative technology for a smart healthcare system to combat coronavirus. The evidence of deep learning applications on the past epidemic inspires the experts by giving a new direction to control this outbreak. The aim of this paper is to discuss the contributions of deep learning at several scales including medical imaging, disease tracing, analysis of protein structure, drug discovery, and virus severity and infectivity to control the ongoing outbreak. A progressive search of the database related to the applications of deep learning was executed on COVID-19. Further, a comprehensive review is done using selective information by assessing the different perspectives of deep learning. This paper attempts to explore and discuss the overall applications of deep learning on multiple dimensions to control novel coronavirus (COVID-19). Though various studies are conducted using deep learning algorithms, there are still some constraints and challenges while applying for real-world problems. The ongoing progress in deep learning contributes to handle coronavirus infection and plays an effective role to develop appropriate solutions. It is expected that this paper would be a great help for the researchers who would like to contribute to the development of remedies for this current pandemic in this area.

Keywords: Novel coronavirus, COVID-19, Pandemic, Deep learning, Diagnosis

Introduction

The novel coronavirus was first detected in December 2019 and spread around the globe rapidly. Now, it has affected almost every country with forty million confirmed cases and more than a million deaths on 18th October 2020 [1]. It has created a tremendous impact on healthcare facilities as well as an economic crisis. To prevent the spread of COVID-19, several national governments have introduced ‘lockdown’ to measure ‘social distancing’ and ‘isolation’ guidelines that limit the movement of people [2]. The coronavirus symptoms can range from cold to fever, as well as acute respiratory illness [3]. The infection of coronavirus is transmitted predominantly via droplets [4].

From the time of civilization, several diseases like heart disease [5], diabetes [6], liver disorder [7], breast cancer [810], COVID-19 [1113], etc. caused severe and acute actions on human health, and artificial intelligence-based systems show better performance to identify those diseases. Fighting against COVID-19, modern technologies are playing significant roles in the development of a smart healthcare system [14, 15]. For example, a facial recognition system is used to trace the infected patients, and robots are used to deliver food and medicine in hospital and drones are applied to disinfect streets [16, 17]. Besides, the researchers around the globe are looking for emerging technologies to monitor and control this virus. Deep learning is such a technology that can be able to diagnose COVID-19 infected patients using radiological images and also used to discover new drugs and medicine so that it can recover infected patients and also utilized to produce a vaccine.

This paper focuses on the contributions of deep learning techniques to fight against the global pandemic. It provides a comprehensive review of deep learning applications that support the world healthcare system by reducing and suppressing the epidemic’s impact. The most recent applications are described throughout the study. The current challenges of existing systems with potential future directions are also outlined in this paper.

The remaining parts of the paper are arranged as follows. “Deep Learning Applications for COVID-19” described the most recent applications of deep learning techniques to combat ongoing pandemic in detail. The summary of the reviewed works is depicted in “Discussions”. In addition, the challenges of existing systems with possible future trends are demonstrated in “Discussions”. Lastly, “Conclusion” concludes the paper.

Deep Learning Applications for COVID-19

Deep learning is a subset of artificial intelligence that contains multiple layers to analyze data. In this model, data are filtered through several layers, where each successive layer using the output of the previous one to produce its output. The analysis of biomedical and healthcare problems helps medical professionals and researchers to find out the new scope for serving the healthcare communities. The detection of COVID-19 at an early stage and isolation of the affected people from others is the most crucial step in controlling this pandemic due to high transmissibility. The reverse polymerase chain reaction (RT-PCR) is considered as a key indicator [18] to diagnose COVID-19 cases; however, it is a time-consuming process with a high false-negative rate. Deep learning focuses on medical imaging, disease tracking, protein structure analysis, drug discovery, and virus severity and infectivity to combat coronavirus. Figure 1 shows several applications of deep learning for the COVID-19 pandemic. In recent studies, several works are found that used deep learning techniques to control COVID-19. The recent applications of deep learning are outlined as follows.

Fig. 1.

Fig. 1

Deep learning applications for COVID-19 pandemic

Medical Imaging for Diagnosis

With the rapid spread of COVID-19, there is growing interest in alternative methods for diagnosing coronavirus infection using medical imaging. Deep learning techniques have been used to process and analyze X-rays as well as computed tomography (CT) to help the doctor to predict COVID-19 infection [19, 20]. Several works are introduced, focusing on the detection of coronavirus using deep learning. Wang and Wong [21] proposed a convolutional neural network-based system named COVID-Net to distinguish COVID-19 cases from others by analyzing lung conditions from X-ray images. A modified Inception model is introduced for extracting the feature of COVID-19 using CT scans with 89.5% accuracy [22]. A 3D deep learning system based on the location-attention mechanism is developed to identify infected regions of COVID-19 patients utilizing CT scans. The system achieved 86.7% accuracy for differentiating COVID-19 pneumonia from Influenza-A viral pneumonia [23]. For the detection of coronavirus, a deep neural network is trained on CT images to distinguish infected parts from other lung diseases [24]. Song et al. [25] developed a ResNet architecture to extract complex features from CT samples and merged a feature pyramid network with an attention module for the classification of COVID-19. A diagnosis system is introduced to identify coronavirus symptoms utilizing CT scans to separate COVID-19 cases [26]. Islam et al. [27] proposed a combined Convolutional Neural Network (CNN) and Long Short-Term Memory (LSTM) architecture to identify coronavirus infected patients from chest X-rays. The deep learning applications for medical imaging-based COVID-19 diagnosis are summarized in Table 1.

Table 1.

Summarization of deep learning applications for medical imaging-based COVID-19 diagnosis

Authors Sample size Methods Results
Khan et al. [19] 1300 chest X-rays including 290 COVID-19 cases CoroNet: Xception architecture Accuracy = 89.6%
Wu et al. [20] 495 CT images consisting of 368 COVID-19 cases Multi-view fusion model using deep learning techniques

Accuracy = 70.0%

AUC = 73.2%

Wang and Wong [21] 13,975 X-ray images from 13,870 patients COVID-Net: deep CNN architecture Accuracy = 92.4%
Wang et al. [22] 325 CT scans of COVID-19 and 740 of pneumonia Deep transfer learning using modified Inception

Accuracy = 79.3%

Specificity = 83.0%

Butt et al. [23] 618 CT images including 219 COVID-19 cases 3D deep learning with location-attention mechanism Accuracy = 86.7%
Jin et al. [24] 970 CT images from 496 patients Deep neural network

Accuracy = 94.98%

Specificity = 95.47%

Song et al. [25] 275 CT scans comprising of 88 COVID-19 cases DeepPneumonia: ResNet architecture

AUC = 99.0%

Sensitivity = 93.0%

Islam et al. [27] 421 X-ray images including 141 COVID-19 cases Combined deep CNN-LSTM architecture

Accuracy = 97%

Specificity = 91%

Disease Tracking

Deep learning techniques are frequently applied to track the spread of COVID-19 infection over time and space. Instead of medical imaging, depth camera footage can be used to analyze respiratory patterns to predict tachypnea [28]. The researchers applied bidirectional Gated recurrent unit (GRU) and attentional techniques to forecast tachypnea that could be a first-order diagnostic feature to contribute large-scale screening of COVID-19 patients. Smartphone sensors are utilized to find COVID-19 symptoms based on a deep learning algorithm to track the COVID-19 pandemic [29]. Ye et al. [30] introduced α-satellite to identify geographical risk assessment at community levels. The large-scale real-time data are applied to deep neural networks to learn the public perceptions and estimated the risk level. A forecast model based on LSTM networks is developed to predict the trend of the COVID-19 outbreak in Canada [31]. Dutta et al. [32] presented a combined LSTM and GRU model to measure positive, negative, death, and release cases of COVID-19 for estimating the position of the current epidemic. This information can be used to take appropriate steps to control the virus infection.

Epidemiological Modelling and Medicines

Computational biologists are helping to battle against COVID-19 by disease modeling and identifying effective drugs in this pandemic. It has been used to understand the protein structure of coronavirus to discover drugs for potential treatment. The dynamic modeling of the disease can contribute to identify the essential parameters that are responsible for the spread of infection and the impact of mediation to control this pandemic [33]. The ground-glass opacities are found in both lungs when the virus increases in the body. Drug repurposing is proposed to identify the patient’s illness that can be treated using existing medications.

Protein Structure Prediction

While entering the RNA genome into a cell, it combines with the host's protein production to duplicate RNA molecules by utilizing it. This is called "polymerase" that is used for a target in treatments [34]. Three-dimensional (3D) protein structure is determined by their genetically encoded amino acid sequence that impacts the function of the protein. Template modeling and template-free modeling are two approaches for the prediction task. For template sequence, template modeling predicts similar protein structures, and template-free modeling predicts unknown related structures [35]. Senior et al. [36] proposed an architecture called AlphaFold based on extended ResNet network [37] that used amino acid sequences and also extracted features using several sequences alignment from its to find out the distance and dispersal of angles between amino acid residues. This system is applied to predict several proteins structure related to COVID-19 [38]. Though these predictions still need to be verified experimentally, it would be helpful to perceive the functionality of coronavirus as well as medicine development for COVID-19.

Drug Discovery

In this COVID-19 pandemic, the crucial step is to identify the right drugs that can be committed for better treatment. There are some researches that are trying to discover effective drugs using deep learning architecture for COVID-19. Zhavoronkov et al. [39] utilized a pipeline to detect inhibitors for the 3C-like protease. The system used three types of information, such as crystal protein structure, co-crystallized ligands, and the homology model of the protein. For every case, several networks, including Generative Auto-encoders (GAs) and Generative Adversarial Networks (GANs), are used [40]. The system analyzed the potential candidate to incorporate factors like novelty, diversity, and medication measurement. Moreover, the author ensured that the detected candidate molecules are different from the existing compound. Tang et al. [41] used reinforcement learning techniques to discover the compounds that inhibit COVID-19. The system generated 284 molecules and broke down the protein into 316 fragments, which later combined using a deep Q-learning network to design a fragment-based drug. Beck et al. [42] applied a deep learning-based system to identify the available drugs that could act against COVID-19 infection. The result showed that the existing drug named atazanavir could be potentially repurposed to treat coronavirus. Patankar et al. [43] generated new molecules using deep learning techniques to discover drugs for COVID-19. An atom of error could be occurred in the training phase of the system using limited data. Zhang et al. [44] used a deep learning method to predict suitable antivirals that might be helpful for COVID-19 patients. The system applied a modified DenseNet network to identify protein–ligand interaction and then used an RNA sequence of coronavirus with chemical compounds to develop an effective drug.

Virus Severity and Infectivity

Viral host prediction is a crucial task to assure biosafety for evolving viruses rapidly. It is difficult to detect human-infecting viruses using bioinformatics systems. Bartoszewicz et al. [45] proposed an approach to predict whether a virus can infect the human-body directly utilizing next-generation sequence. The system showed that CNN and LSTM-based architecture outperformed the other machine learning algorithms and generalized to taxonomic units with a half error rate from those that are presented in the training phase. The visualization of nucleotide data is done in convolutional filters. Finally, GWPA plots are used to insight the behavior of the system to analyze the COVID-19 virus. Guo et al. [46] introduced virus-host prediction technique based on a deep learning algorithm to identify what types of a viral host can infect a human with DNA input sequence. The prediction result showed that various vertebrate infectious coronavirus has good strength for infecting humans. This system is also effective for virus analysis and prevention in an early stage.

Discussions

This paper introduced a survey of deep learning applications to reduce the crisis of humanity that are faced due to COVID-19 and control strategies of this pandemic. In particular, we highlighted emerging applications such as medical imaging for diagnosis, disease tracking, protein structure analysis, drug discovery, and virus severity and infectivity which are summarized in Table 2. To classify COVID-19 cases, the system developed in [19, 27] used a different number of X-ray images and achieved 97% and 89.6% accuracy, respectively. On the contrary, the schemes introduced in [20, 2225] applied a various range of CT scans and obtained the highest 94.98% accuracy to distinguish coronavirus symptoms. To track the outbreak of COVID-19, the proposed systems in [2931] applied a deep learning algorithm on real-time data to take appropriate steps. In the field of epidemiological modeling and medicines, deep learning is used to explore and analyze the protein structure of the virus to identify the essential components for the vaccine [36]. For the development of effective drugs, the systems demonstrated in [39] trained GAs and GANs, [41] used reinforcement learning techniques, and [43] applied LSTM networks. The human-infecting virus can be identified using deep learning-based architectures utilizing its next-generation sequence shown in [45].

Table 2.

Summarization of deep learning applications to combat COVID-19 pandemic

Sl. no. Applications Descriptions
1 Diagnosis using medical imaging

Deep learning architecture is used to extract complex features from radiological images for proper diagnosis

Early prediction of COVID-19 infection using different CNN architecture from an increasing number of samples

CoroNet is based on Xception architecture used for the diagnosis of coronavirus infection from X-ray images

COVID-Net used a deep CNN architecture to distinguish COVID-19 cases from pneumonia and normal cases

DeepPneumonia used ResNet architecture for the classification of COVID-19 symptoms from CT scans

2 Disease tracking

Bidirectional GRU and attentional techniques are used for the analysis of respiratory patterns to contribute large scale COVID-19 screening

A dynamic neural network is applied to identify the geographical spread of coronavirus pandemic

AI-driven system used deep learning algorithms to identify geographical risk at community levels

3 Protein structure prediction

Critical assessment of techniques for protein structure prediction based on a deep neural network to identify protein characteristics

CNN architecture is utilized to examine dense predictions

The deeper ResNet network is applied to ease the training of models to recognize infected images

4 Drug discovery

GANs and GAs are utilized as a pipeline that generates essential drug compounds

Reinforcement learning techniques are implemented to discover the compounds that inhibit COVID-19

Deep learning techniques are focused on generating new molecules to treat coronavirus

5 Virus severity and infectivity

CNN and LSTM-based systems showed the better performance to predict virus infectivity in the human body

Virus-host prediction techniques used deep learning algorithms to analyze virus and early prevention

In recent years, many researchers are employing deep learning for COVID-19 cases, but the data about COVID-19 are still limited. Among them, the use of deep learning for the diagnosis of COVID-19 from medical imaging data seems to be dominant from others, but few systems still have some lack of transparency and interpretability. This means it is still unknown which imaging feature is responsible for generating output. Hence, it is necessary to explain the features of the medical image with the performance of the developed architecture that are responsible for differentiating COVID-19 cases from others, and it would be helpful to doctor to gain insights about the virus. The data of COVID-19 on case reporting are varying from country to country that may not represent the true transmission rate and also can create an issue for disease tracking. To discover drugs, some systems need longer length peptides against coronavirus protease on virtual screening and also need to develop a scoring function to redesign the antibodies of COVID-19. However, the number of deep learning applications would be significantly increased when more data would be available.

Conclusion

COVID-19 outbreak is still now an ongoing pandemic and outperforming the previous records of all communicable diseases in terms of infection and death cases. The researchers investigate all the potential steps to combat the COVID-19 pandemic that are reviewed in this paper. Deep learning has a significant impact on identifying coronavirus infection at an early stage for the proper treatment. It also tries to track the COVID-19 crisis at different scales, such as medical, molecular, and epidemiological, to enhance public healthcare systems. Deep learning-based system is also helpful in facilitating virus analysis for proper drugs and vaccine development. Although the impact of deep learning is so far limited, it would provide a better outcome to handle this crisis. Hopefully, this deep learning-based application will be helpful in developing appropriate solutions to combat the current pandemic.

Funding

No funding sources.

Compliance with Ethical Standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Footnotes

This article is part of the topical collection “Advances in Computational Approaches for Artificial Intelligence, Image Processing, IoT and Cloud Applications” guest edited by Bhanu Prakash K. N. and M. Shivakumar.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Amanullah Asraf, Email: amanullahoasraf@gmail.com.

Md. Zabirul Islam, Email: zabir.kuet.cse@gmail.com.

Md. Rezwanul Haque, Email: rezwanh001@gmail.com.

Md. Milon Islam, Email: milonislam@cse.kuet.ac.bd.

References

  • 1.Worldometer, Coronavirus Cases, Worldometer. (2020) 1–22. 10.1101/2020.01.23.20018549V2.
  • 2.Advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. Accessed 14 July 2020.
  • 3.Coronavirus Disease 2019 (COVID-19)|CDC. https://www.cdc.gov/coronavirus/2019-nCoV/index.html. Accessed 14 July 2020.
  • 4.Haleem A, Javaid M, Vaishya R. Effects of COVID-19 pandemic in daily life. Curr Med Res Pract. 2020;10:78–79. doi: 10.1016/j.cmrp.2020.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ayon SI, Islam MM, Hossain MR. Coronary artery heart disease prediction: a comparative study of computational intelligence techniques. IETE J Res. 2020 doi: 10.1080/03772063.2020.1713916. [DOI] [Google Scholar]
  • 6.Ayon SI, Islam MM. Diabetes prediction: a deep learning approach. Int J Inf Eng Electron Bus. 2019;11:21–27. doi: 10.5815/ijieeb.2019.02.03. [DOI] [Google Scholar]
  • 7.Haque MR, Islam MM, Iqbal H, Reza MS, Hasan MK. Performance evaluation of random forests and artificial neural networks for the classification of liver disorder. In: 2018 International conference on computer, communication, chemical, material and electronic engineering (IC4ME2), 2018, p. 1–5. 10.1109/IC4ME2.2018.8465658.
  • 8.Islam MM, Haque MR, Iqbal H, Hasan MM, Hasan M, Kabir MN. Breast cancer prediction: a comparative study using machine learning techniques. SN Comput Sci. 2020;1:290. doi: 10.1007/s42979-020-00305-w. [DOI] [Google Scholar]
  • 9.Islam MM, Iqbal H, Haque MR, Hasan MK. Prediction of breast cancer using support vector machine and K-Nearest neighbors. In: 2017 IEEE Region 10 humanitarian technology conference, 2017. p. 226–9. 10.1109/R10-HTC.2017.8288944.
  • 10.Hasan MK, Islam MM, Hashem MMA, Mathematical model development to detect breast cancer using multigene genetic programming. In: 5th International conference on informatics, electronics and vision, 2016. p. 574–9. 10.1109/ICIEV.2016.7760068.
  • 11.Muhammad LJ, Islam MM, Usman SS, Ayon SI. Predictive data mining models for novel coronavirus (COVID-19) infected ‘patients’ recovery. SN Comput Sci. 2020;1:206. doi: 10.1007/s42979-020-00216-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Islam MM, Karray F, Alhajj R, Zeng J. A review on deep learning techniques for the diagnosis of novel coronavirus (COVID-19). 2020. https://arxiv.org/abs/2008.04815. [DOI] [PMC free article] [PubMed]
  • 13.Islam MM, Islam MZ, Asraf A, Ding W. Diagnosis of COVID-19 from X-rays using combined CNN-RNN architecture with transfer learning. medRxiv. 2020 doi: 10.1101/2020.08.24.20181339v1. [DOI] [Google Scholar]
  • 14.Islam MM, Rahaman A, Islam MR. Development of smart healthcare monitoring system in IoT environment. SN Comput Sci. 2020;1:185. doi: 10.1007/s42979-020-00195-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rahaman A, Islam M, Islam M, Sadi M, Nooruddin S. Developing IoT based smart health monitoring systems: a review. Rev Intell Artif. 2019;33:435–440. doi: 10.18280/ria.330605. [DOI] [Google Scholar]
  • 16.Kumar A, Gupta PK, Srivastava A. A review of modern technologies for tackling COVID-19 pandemic. Diabetes Metab Syndr Clin Res Rev. 2020;14:569–573. doi: 10.1016/j.dsx.2020.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.The Uses of Drones in Case of Massive Epidemics Contagious Diseases Relief Humanitarian Aid: Wuhan-COVID-19 Crisis by Mario Arturo Ruiz Estrada:: SSRN. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3546547. Accessed 14 July 2020.
  • 18.Emery SL, Erdman DD, Bowen MD, Newton BR, Winchell JM, Meyer RF, Tong S, Cook BT, Holloway BP, McCaustland KA, Rota PA, Bankamp B, Lowe LE, Ksiazek TG, Bellini WJ, Anderson LJ. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis. 2004;10:311–316. doi: 10.3201/eid1002.030759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Khan AI, Shah JL, Bhat MM. CoroNet: a deep neural network for detection and diagnosis of COVID-19 from chest X-ray images. Comput Methods Programs Biomed. 2020 doi: 10.1016/j.cmpb.2020.105581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wu X, Hui H, Niu M, Li L, Wang L, He B, Yang X, Li L, Li H, Tian J, Zha Y. Deep learning-based multi-view fusion model for screening 2019 novel coronavirus pneumonia: a multicentre study. Eur J Radiol. 2020;128:1–9. doi: 10.1016/j.ejrad.2020.109041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wang L, Wong A. COVID-Net: a tailored deep convolutional neural network design for detection of COVID-19 cases from chest X-ray images. 2020. arXiv:2003.09871. [DOI] [PMC free article] [PubMed]
  • 22.Wang S, Kang B, Ma J, Zeng X, Xiao M, Guo J, Cai M, Yang J, Li Y, Meng X, Xu B. A deep learning algorithm using CT images to screen for corona virus disease (COVID-19) medRxiv. 2020 doi: 10.1101/2020.02.14.20023028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Butt C, Gill J, Chun D, Babu BA. Deep learning system to screen coronavirus disease pneumonia. Appl Intell. 2019 doi: 10.1007/s10489-020-01714-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Cheng Jin JF, Chen W, Cao Y, Zhanwei X, Zhang X, Deng L, Zheng C, Zhou J, Shi H. Development and evaluation of an AI system for COVID-19 diagnosis. medRxiv. 2020 doi: 10.1101/2020.03.20.20039834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ying Y, Zheng S, Li S, Zhang L, Zhang X, Huang X, Chen Z, Zhao J, Jie H, Wang Y, Chong R, Shen Y, Zha J, Yang Y. Deep learning enables accurate diagnosis of novel coronavirus (COVID-19) with CT images. medRxiv. 2020 doi: 10.1101/2020.02.23.20026930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Takahashi MS, Ribeiro Furtado de Mendonça M, Pan I, Pinetti RZ, Kitamura FC. Regarding “serial quantitative chest CT assessment of COVID-19: deep-learning approach”. Radiol Cardiothorac Imaging. 2020;2:e200242. doi: 10.1148/ryct.2020200242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Islam MZ, Islam MM, Asraf A. A combined deep CNN-LSTM network for the detection of novel coronavirus (COVID-19) using X-ray images. Inform Med Unlocked. 2020;20:100412. doi: 10.1016/j.imu.2020.100412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Wang Y, Hu M, Li Q, Zhang X-P, Zhai G, Yao N. Abnormal respiratory patterns classifier may contribute to large-scale screening of people infected with COVID-19 in an accurate and unobtrusive manner. 2020. arXiv:2002.05534.
  • 29.Maghdid HS, Ghafoor KZ, Sadiq AS, Curran K, Rabie K. A novel AI-enabled framework to diagnose coronavirus COVID 19 using smartphone embedded sensors: design study. 2020;1–7. arXiv:2003.07434.
  • 30.Ye Y, Hou S, Fan Y, Qian Y, Zhang Y, Sun S, Peng Q, Laparo K. α-Satellite: an AI-driven system and benchmark datasets for hierarchical community-level risk assessment to help combat COVID-19. 2020. arXiv:2003.12232 [DOI] [PMC free article] [PubMed]
  • 31.Chimmula VKR, Zhang L. Time series forecasting of COVID-19 transmission in Canada using LSTM networks. Chaos Solitons Fractals. 2020 doi: 10.1016/j.chaos.2020.109864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bandyopadhyay SK, Dutta S. Machine learning approach for confirmation of COVID-19 cases: positive, negative, death and release. medRxiv. 2020 doi: 10.1101/2020.03.25.20043505. [DOI] [Google Scholar]
  • 33.Ferguson N, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M, Bhatia S, Boonyasiri A, Cucunubá Z, Cuomo-Dannenburg G, Dighe A. Report 9—Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. London: Imperial College; 2020. [Google Scholar]
  • 34.Joynt GM, Wu WK. Understanding COVID-19: what does viral RNA load really mean? Lancet Infect Dis. 2020;20:635–636. doi: 10.1016/S1473-3099(20)30237-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Yu F, Koltun V. Multi-scale context aggregation by dilated convolutions. In: 4th International conference learning represent. ICLR 2016—conference track proceedings 2016.
  • 36.AlphaFold: Using AI for scientific discovery|DeepMind. https://deepmind.com/blog/article/alphafold-casp13. Accessed 07 July 2020.
  • 37.He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. In: Proceedings of the IEEE conference on computer vision and pattern recognition. 10.1109/CVPR.2016.90.
  • 38.Computational predictions of protein structures associated with COVID-19|DeepMind. https://deepmind.com/research/open-source/computational-predictions-of-protein-structures-associated-with-COVID-19. Accessed 07 July 2020.
  • 39.Zhavoronkov A, Aladinskiy V, Zhebrak A, Zagribelnyy B, Terentiev V, Bezrukov DS, Polykovskiy D, Shayakhmetov R, Filimonov A, Orekhov P, Yan Y, Popova O, Vanhaelen Q, Aliper A, Ivanenkov Y. Potential 2019-nCoV 3C-like protease inhibitors designed using generative deep learning approaches. Insilico Med. 2020 doi: 10.26434/chemrxiv.11829102.v2. [DOI] [Google Scholar]
  • 40.Makhzani A, Shlens J, Jaitly N, Goodfellow I, Frey B. Adversarial autoencoders. 2015. arXiv:1511.05644.
  • 41.Tang B, He F, Liu D, Fang M, Wu Z, Xu D. AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2. BioRxiv Prepr Serv Biol. 2020 doi: 10.1101/2020.03.03.972133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Beck BR, Shin B, Choi Y, Park S, Kang K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Comput Struct Biotechnol J. 2020;18:784–790. doi: 10.1016/j.csbj.2020.03.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Patankar S. Deep learning-based computational drug discovery to inhibit the RNA dependent RNA polymerase: application to SARS-CoV and COVID-19. 2020. https://Osf.Io/6Kpbg/.
  • 44.Zhang H, Saravanan KM, Yang Y, Hossain MT, Li J, Ren X, Pan Y, Wei Y. Deep learning based drug screening for novel coronavirus 2019-nCov. Interdiscip Sci Comput Life Sci. 2020;19:1–17. doi: 10.1007/s12539-020-00376-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Bartoszewicz JM, Seidel A, Renard BY. Interpretable detection of novel human viruses from genome sequencing data. BioRxiv. 2020 doi: 10.1101/2020.01.29.925354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Zhu H, Guo Q, Li M, Wang C, Fang Z, Wang P, Tan J, Wu S, Xiao Y. Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm. BioRxiv. 2020. 10.1101/2020.01.21.914044.

Articles from Sn Computer Science are provided here courtesy of Nature Publishing Group

RESOURCES